Roche Tests MiniMed, Brings Marketing Muscle To Disetronic Insulin Delivery

Medtronic MiniMed will have to contend with the emergence of Disetronic's insulin infusion pumps, backed by Roche's extensive sales presence, on the U.S. diabetes care market

More from Archive

More from Medtech Insight